Tetraspan [特慕血舒] - Taiwan - 全球药品采购网

TOP

Tetraspan [特慕血舒]

2014-09-22 13:48:04 来源: 作者: 【大中小】浏览:816次评论:0条

健保碼及健保價
See related Tetraspan[特慕血舒] information

製造商	B Braun
代理/經銷商	B Braun
成份	Per 1 L 6%/10% soln Hydroxyethyl Starch (Molar substitution: 0.42; Ave molecular wt: 130,000 Dalton) 60 g or 100 g. Electrolyte conc: Na 140 mmol, K 4 mmol, Ca 2.5 mmol, Mg 1 mmol, Cl 118 mmol, acetate 24 mmol, malate 5 mmol.
適應症	Treatment & prophylaxis of hypovolaemia & shock
用量	Initially 10-20 mL slow infusion. Max daily dose: 50 mL Tetraspan 6%/kg or 30 mL Tetraspan 10%/kg. Acute shock 20 mL/kg/hr. Life-threatening situation 500 mL rapid manual pressure infusion.
過量	View Tetraspan[特慕血舒] overdosage for action to be taken in the event of an overdose.
禁忌	Hyperhydration states including pulmonary edema, renal failure with oliguria or anuria, intracranial hemorrhage, hyperkalemia, severe hypernatraemia or hyperchloremia, severe hepatic impairment, CHF.
注意事項	Monitor serum electrolyte, fluid balance & renal function. Heart failure, hepatic or renal failure, blood coagulation disorder. Childn. Pregnancy & lactation.
不良反應	Hemodilution, decreased hematocrit & plasma protein conc, coagulation factor dilution, prolonged bleeding time & aPTT, reduced FVIII/vWF complex levels, raised serum α-amylase level, anaphylactic reaction. View ADR Monitoring Website[參閱藥物不良反應監測表格]
交互作用	Drugs that cause K or Na retention. Digitalis. View more drug interactions with Tetraspan[特慕血舒]
使用上注意	For caution against possible variation of physical aspect of medicine... click to view Tetraspan[特慕血舒] detailed prescribing infomation
儲存	View Tetraspan[特慕血舒] storage conditions for details to ensure optimal shelf-life.
描述	View Tetraspan[特慕血舒] description for details of the chemical structure and excipients (inactive components).
作用	View Tetraspan[特慕血舒] mechanism of action for pharmacodynamics and pharmacokinetics details.